. "Appendix F: Speaker Biographies." The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies: Workshop Summary. Washington, DC: The National Academies Press, 2011.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies
Dr. Emanuel has been involved in developing President Obama’s Global Health Initiative.
He has received numerous awards including election to the Institute of Medicine (IOM) of the National Academy of Sciences and the Association of American Physicians. After completing Amherst College, Dr. Emanuel received an M.Sc. in biochemistry from Oxford University and then attended Harvard University, where he earned his M.D. from the medical school and a Ph.D. in political philosophy.
Christopher Eppig has been a Ph.D. student in the Human Evolutionary and Behavioral Sciences Program and the Biology Department at the University of New Mexico since 2005. He has conducted research on humans in diverse areas, including chemical communication, social behavior, endocrinology, male sexual behavior, and intelligence. His research has been widely covered by international media, including The Economist, The Guaridan, Newsweek, and ScienceNow.
Mark B. Feinberg, M.D., Ph.D.,1 is vice president for medical affairs and policy in global vaccine and infectious diseases at Merck & Co., Inc., and is responsible for global efforts to implement vaccines to achieve the greatest health benefits, including efforts to expand access to new vaccines in the developing world. Dr. Feinberg received a bachelor’s degree magna cum laude from the University of Pennsylvania in 1978 and his M.D. and Ph.D. degrees from Stanford University School of Medicine in 1987. His Ph.D. research at Stanford was supervised by Dr. Irving Weissman and included time spent studying the molecular biology of the human retroviruses—human T-cell lymphotrophic virus, type I (HTLV-I) and HIV—as a visiting scientist in the laboratory of Dr. Robert Gallo at the National Cancer Institute. From 1985 to 1986, Dr. Feinberg served as a project officer for the IOM Committee on a National Strategy for AIDS. After receiving his M.D. and Ph.D. degrees, Dr. Feinberg pursued postgraduate residency training in internal medicine at the Brigham and Women’s Hospital of Harvard Medical School and postdoctoral fellowship research in the laboratory of Dr. David Baltimore at the Whitehead Institute for Biomedical Research. From 1991 to 1995, Dr. Feinberg was an assistant professor of medicine and microbiology and immunology at the University of California, San Francisco (UCSF), where he also served as an attending physician in the AIDS-oncology division and as director of the virology research laboratory at San Francisco General Hospital. From 1995 to 1997, Dr. Feinberg was a medical officer in the Office of AIDS Research in the Office of the Director of the NIH, the chair of the NIH Coordinating Committee on AIDS Etiology and Pathogenesis Research, and an attending physician at the NIH Clinical Center. During this period, he also served as Executive Secretary of the NIH Panel to Define Principles of Therapy of HIV Infection. Prior to joining